Hipro Biotechnology
Healthcare Services · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
3938 Trust Way, Hayward, California, 945...Phone Number
(510) 314-1975Website
www.hipro.usRevenue
$18 MillionIndustry
ZI Rank: 2
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
3
3
2
2
2
About Hipro Biotechnology
Hipro Biotechnology is a leading IVD and POCT manufacturer specializing in advanced medical instrument manufacturing and in vitro diagnostic solutions. The company focuses on research and development, manufacturing, and marketing of point-of-care products, offering a diverse portfolio that includes immunoassay analyzers and diagnostic reagents. With a presence in over 100 countries, Hipro is committed to providing superior service and innovative diagnostic systems to healthcare providers. Founded in 2006, Hipro has established itself as a trusted supplier in the healthcare field, backed by a strong emphasis on quality control and technological innovation.Explore more
Hipro Biotechnology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Hipro Biotechnology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Hipro Biotechnology, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Hipro Biotechnology recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Hipro Biotechnology is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Hipro Biotechnology
Funding: Get notified immidiatlly once Hipro Biotechnology has new funding data
Click to see if Hipro Biotechnology had a recent Job posting/layoffs
Product Launch: Get notified when Hipro Biotechnology launches new products
Check if Hipro Biotechnology has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Hipro Biotechnology as Masked Content
Find 3 more new buyers
Compare Similar Companies to Hipro Biotechnology
Compare insights from companies similar to Hipro Biotechnology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Hipro Biotechnology is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Hipro Biotechnology is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Hipro Biotechnology.
Hipro Biotechnology Tech Stack
A closer look at the technologies used by Hipro Biotechnology
Most Recent Scoops
Event
Product Marketing, Events, Training, Sales, Learning & Development, Search, Laboratory Operations, Medical Education & Training, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Technology, HR Operations, Operations
Event
will be attending the Medlab Middle East 2023 conference as an exhibitor. The event will occur from February 6 to February 9, 2023.
Event
will be attending the 2022 AACC Annual Scientific Meeting + Clinical Lab Expo conference as an exhibitor. The event will occur from July 24 to July 28, 2022.
Event
Hipro Biotechnology News & Media
Qlife signs collaboration agreement with Hipro Biotechnology
Qlife has recently announced the signing of a Letter of Intent (LOI) with a leading industry partner, Hipro Biotechnology, as a component of its B2B strategy to enter key markets with the Egoo Health system. Qlife is now pleased to announce the signing of a collaboration agreement. The agreement in brief The agreement consists of four major parts: 1. Integration of reagents 2. Regulatory approval from the China Food and Drug Administration for Egoo HealthQlife signs letter of intent with major industry partner as part of a the b2b strategy to enter major markets with Egoo Health, through hospital-at-home partnerships.
Qlife is pleased to announce that it has signed a Letter of Intent (LOI) with major industry player, Hipro Biotechnology, to introduce Egoo Health to the Chinese market. Qlife anticipate finalizing a comprehensive collaboration agreement by the end of this year. The technology and overall strategy Qlife has invested more than SEK 300 million in the development of Egoo Health, a unique biomarker self-testing system for measuring and monitoring blood data at clinical-grade level at-home,
Read more news
Top Healthcare Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Hipro Biotechnology
Sign Up For FreeTo access detailed company insights
Hipro Biotechnology is a leading IVD and POCT manufacturer specializing in advanced medical instrument manufacturing and in vitro diagnostic solutions. The company focuses on research and development, manufacturing, and marketing of point-of-care products, offering a diverse portfolio that includes immunoassay analyzers and diagnostic reagents. Wit... Read More
